Adipose tissue lipolysis is the catabolic process whereby stored triacylglycerol (TAG) is broken down by lipases into fatty acids and glycerol. Here, we review recent insights from transgenic mouse models. Genetic manipulations affecting lipases are considered first, followed by transgenic models of lipase co-factors and lastly non-lipase lipid droplet (LD)-associated proteins. The central role of hormone-sensitive lipase (HSL), long considered to be the sole rate-limiting enzyme of TAG hydrolysis, has been revised since the discovery of adipose triglyceride lipase (ATGL). It is now accepted that ATGL initiates TAG breakdown producing diacylglycerol, which is subsequently hydrolyzed by HSL. Furthermore, lipase activities are modulated by co-factors whose deletion causes severe metabolic disturbances. Another major advance has come from the description of the involvement of non-lipase proteins in the regulation of lipolysis. The role of perilipins has been extensively investigated. Other newly discovered LD-associated proteins have also been shown to regulate lipolysis.
Introduction
Adipose tissue is specialized in energy storage as fat. During the postprandial state, surplus glucose and fatty acids (FAs) are converted into triacylglycerol (TAG), an energetically efficient storage form. When energetic substrates are required by the body (for example, when fasting or exercising) adipose tissue converts the stored TAG into fuel molecules, FA, to be metabolized by tissues such as skeletal muscle and liver. Adipose tissue also buffers peripheral tissues from FA exposure. But when adipose tissue reaches its limit in terms of expandability other tissues start to accumulate fat. This ectopic fat deposition is well known to cause lipotoxic effects and metabolic disturbances commonly leading to insulin resistance. An imbalance in fat deposition/mobilization can therefore lead to insulin resistance and associated disorders such as diabetes, non-alcoholic fatty liver disease and dyslipidemia.
Adipocytes regulate the balance between TAG storage and FA release. TAG is stored in lipid droplets (LDs) so that other intracellular organelles are protected from lipotoxicity caused by FA. LDs consist of a core of TAG surrounded by a monolayer of phospholipids and specific proteins. Lipolysis involves the sequential enzymatic breakdown of TAG by lipases, leading to the formation of one molecule of glycerol and three molecules of FA when the process is complete. 1 The first ester bond of TAG is preferentially hydrolyzed by adipose triglyceride lipase (ATGL, Table 1 ). This rate-limiting reaction yields diacylglycerol (DAG) and FA. Hormonesensitive lipase (HSL) then cleaves DAG leading to the formation of monoacylglycerol (MAG) and FA. In vitro, HSL also shows TAG hydrolase activity. The final step of lipolysis is catalyzed by monoglyceride lipase (MGL), which hydrolyzes MAG into glycerol and FA. In vitro studies on isolated human and rodent fat cells as well as on murine adipocyte cell lines have brought a wealth of information on the regulation of lipolysis. [2] [3] [4] In human fat cells, catecholamines increase intracellular 3'-5'-cyclic adenosine monophosphate levels and activate protein kinase A whereas natriuretic peptides increase 3'-5'-cyclic guanosine monophosphate levels and activate protein kinase G. Antilipolytic pathways decrease intracellular 3'-5'-cyclic adenosine monophosphate levels by inhibiting adenylyl cyclase-mediated 3'-5'-cyclic adenosine monophosphate production and/or by promoting 3'-5'-cyclic adenosine monophosphate degradation by phosphodiesterases. In vitro colocalization and protein-protein interaction studies elucidated the molecular events occurring at the LD surface in the basal state and following lipolytic stimulation. In the basal (unstimulated) state, HSL remains in the cytosol while ATGL, perilipin and the ATGL co-activator ABHD5 (abhydrolase domain containing 5) are located at the LD surface. Perilipin and ABHD5 form a complex, maintaining the latter in an inactive state and thereby limiting basal ATGL-mediated lipolysis ( Figure 1 ). 1 When stimulated, activating pathways trigger protein kinase phosphorylation leading to HSL and perilipin phosphorylation. Phosphorylated HSL migrates from cytosol to the LD where it is enzymaticaly active while LD surface undergoes major rearrangements and fragmentation because of protein kinase-mediated phosphorylation of perilipin. 5 Perilipin phosphorylation is also responsible for ABHD5 release, which can in turn interact with ATGL, to initiate TAG breakdown. [6] [7] [8] Thus, besides intrinsic lipase activity, adipocyte lipolysis is also regulated by the control of lipase access to the LD. Over the past decade, cellular approaches have highlighted the importance of non-enzymatic proteins in lipolysis, illustrated by the role of ABHD5 in ATGL activation or the lipolysis-limiting role of LD-coating proteins such as perilipins, ADRP and CIDEC/Fsp27 forming a physical barrier between core TAG and lipases. On the other hand, LD-associated proteins can also favor lipolysis by docking lipases and enhancing their access to TAG. LDs must therefore be considered as a site where complex finely tuned mechanisms control TAG breakdown, involving lipases as well as non-lipase proteins. Over the past 10 years, transgenic mouse models for adipocyte lipase, co-factors and LD-associated proteins have been produced. This review focuses on the contribution of lipases and LD-associated proteins to the in vivo control of adipose tissue lipolysis and the whole body consequences of alterations in lipolytic capacity.
Genetic alteration of lipase expression
Hormone-sensitive lipase Four HSL-null mouse models have been generated by deleting either the genomic sequence coding the catalytic domain [9] [10] [11] or the region around the translation start codon. 12 In all these models, HSL mRNA and protein were undetectable. Enzymatic TAG hydrolase activity assessed ex vivo was decreased (50-60%) in white adipose tissue and testis but was not altered in other tissues suggesting differences in the relative importance of HSL and other TAG and DAG hydrolases in these tissues. Animal models for the study of lipolysis A Girousse and D Langin depots whereas brown adipose tissue depots were consistently increased. [16] [17] [18] Growth curves indicated that HSL-null mice gain as much weight as the wild-type mice during the early stages of the diet but suddenly stop putting on more weight suggesting a limitation in adipose tissue expandability. The weight gain plateau occurs earlier in older mice. 18 This dissociation in weight curves is not dependent on gender or genetic background and has been observed in different models of HSL-null mice. HSL-null mice were also resistant to genetic-induced obesity when they were bred on the ob/ob background. 19 Three major, but not necessarily mutually exclusive, mechanisms influencing fat deposition may account for the observed resistance to obesity: (1) food intake, (2) energy expenditure and (3) adipogenesis. Reduced weight gain in HSL-null mice is not a result of reduced food intake as it has been observed to be increased or unchanged in two independent models. Unfortunately, the role of leptin in this process was not investigated. Fat absorption was also reported to be unchanged in HSL-null mice, 16, 20 whereas energy expenditure was significantly increased. Whole body oxygen consumption was raised by 30% in HSL-null mice fed HFD for 6 months without any modification in physical activity. 20 The investigators portrayed HSL-null HFD-fed mice as a 'fat-burning model' presenting white adipose tissue with metabolic brown adipocyte-like features including: increased mitochondrial size in adipocytes, induction of uncoupling protein 1 expression and increased O 2 consumption. Harada et al. 16 noted a delayed fall in body temperature and increased body weight loss in fasted HSLnull mice compared with wild-type mice in keeping with an increase in energy expenditure. Reduced fat deposition could also result from impaired adipogenesis and/or adipocyte maturation. The observed reduction of ex vivo radiolabelled non-esterified FA incorporation into TAG and in vitro de novo lipogenesis in white adipose tissue of HSL-null mice support this hypothesis. Expression and enzymatic activity of several adipogenic and lipogenic genes were altered contributing to reduced TAG synthesis and white adipose tissue mass in HSL-null mice. 16, 20, 21 The nuclear receptor peroxysome proliferation-activated receptor-g controls these pathways. It may, therefore, be hypothesized that HSL produces lipidderived ligands activating peroxysome proliferationactivated receptor-g because HSL-null mice treated with a peroxysome proliferation-activated receptor-g agonist partially recover fat mass. 22 However, it is unlikely that HSL is involved in the early stages of adipocyte differentiation because mouse embryonic fibroblasts derived from HSL-null mice differentiate well into mature adipocytes. 23 HSL may be more important in terminal differentiation and cell hypertrophy. 22 DAG accumulation, 16 retinoic acid (another HSL substrate) metabolites and local inflammation can also interfere with adipocyte differentiation. 24 White adipose tissue of HSL-null mice manifests some similar histological features to those of ob/ob mice, 15 including increased macrophage infiltration surrounding necrotic adipocytes, the so-called crown-like structures. 25 Macrophages may be acting as scavengers of FA released by dead hypertrophic adipocytes. However, if adipose tissue is undoubtedly infiltrated by immune cells in HSL-null mice, one cannot assert that this phenomenon is only and directly related to adipocyte hypertrophy because smaller adipocytes with altered metabolic features might also be involved in the recruitment process. The reduced retinyl ester hydrolase activity because of HSL disruption might limit the production of retinoic acid, a potential antiinflammatory molecule suppressing nuclear factor-kB activity. 26 HSL-null mice remain an unusual model of pronounced white adipose tissue inflammation not associated with obesity. Fasted HSL-null mice have improved plasma lipid profiles (reduced TAG, non-esterified FA and very-low-density lipoprotein-cholesterol, increased high-density lipoproteincholesterol). 27 The reduced plasma TAG levels could result from an increase in lipoprotein lipase activity in several tissues (white and brown adipose tissues) or a modification in global FA re-esterification. Assessment of glucose homeostasis and insulin sensitivity in HSL-null mice fed chow diet gave inconsistent results. Whole body glucose uptake measured by hyperinsulinemic euglycemic clamp in the mouse lines of Zechner, Mitchell and Holm was unchanged in HSL-null mice. 11, 17, 28 It was not assessed in Yamada's line. 10 Responses to intraperitoneal glucose tolerance testing in Mitchell's line differed depending on age, HSL-null mice being glucose intolerant at 5 months while showing unaltered or mildly improved glucose tolerance respectively at 4 months or 7 months. In Holm's line, glycemia during glucose tolerance test was maintained in HSL-null mice while insulin was markedly increased implying reduced peripheral insulin sensitivity. 11 Insulin tolerance test revealed insulin-resistance in HSL-null mice in the models of Mitchell and Holm. However, insulin sensitivity investigated in different organs showed conflicting results. Hepatic insulin sensitivity is improved in Zechner's and Mitchell's lines 9,17 but decreased in Holm's line. 11 Insulin-stimulated glucose uptake measured in skeletal muscle was intact in Zechner's line but decreased in Holm's line. In white adipose tissue, insulin-stimulated glucose uptake (only investigated in Holm line) was decreased suggesting several insulinresistant organs in this model. In vitro pancreatic islet challenges revealed reduced 29, 30 or intact 11 glucose-stimulated insulin secretion in HSL-null mice. Beta cell-specific depletion of HSL resulted in hyperglycemia because of impaired insulin secretion. 31 The effects of HFD were only studied in Mitchell's line and showed no change in whole body glucose uptake compared with chow diet whereas those of control mice was decreased. HFD reduced hepatic insulin sensitivity in both genotypes; however, skeletal muscle insulin sensitivity was preserved in HFD-fed HSL-null mice. In conclusion, the effects of HSL deficiency on glucose homeostasis and insulin sensitivity remain controversial. The results reviewed here suffer from heterogeneity in genetic background, animal ages, standard Tissue-specific expression of HSL in adipocytes of HSL-null mice restored fat mass and body weight to the level of wildtype mice. 14 However, adipose HSL rescue modified fat distribution.
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Adipose triglyceride lipase
Studies on HSL-null mice lent support for the existence of another TAG lipase besides HSL. In 2004, three independent groups characterized this new lipase using in silico screening 33, 34 and DNA microarrays. 35 The three candidates are identical and all display TAG hydrolase activity whereas transacylase activity was only reported by Jenkins et al.
34
ATGL is predominantly expressed in white and brown adipose tissue and to a lesser extent in testis, cardiac muscle and skeletal muscles. Genetic manipulations affecting exon 1 including the translational start codon and the lipase consensus sequence motif knocked out ATGL in mice and disrupted protein production. 36 TAG hydrolase activity in adipose tissue was markedly (480%) blunted by ATGL deletion, confirming previous in vitro data. 6 ATGL-null mice manifest markedly blunted in vitro stimulated lipolysis while basal lipolysis was not affected; which differs from cellular observations where reduced lipolysis was shown in the basal state. 6 The major phenotypic consequence of ATGL disruption is massive TAG accumulation in several adipose and non-adipose organs ( Figure 2 ). Supra-physiological TAG accumulation in cardiac muscle (20-fold increase) leads to lethal impairment of cardiac function from 12 weeks of age but can be completely prevented in ATGL-null mice with specific rescue in the heart. 37 When fed a normal chow diet, ATGL-null mice are moderately obese with increased white and brown adipose tissue weight compared with wild-type mice. 36, 38 Accordingly, adipocyte size was substantially increased in white and brown adipose tissues. Global energy metabolism is characterized by an inability to mobilize enough FA as fuel as exemplified by defective thermoregulation, reduced energy expenditure during fasting and impaired exercise-stimulated HSL-null mice from Zechner's group bred on a mixed genetic background show hyperglycemia and hypoinsulinemia. Liver, skeletal muscles and adipose tissue are insulin-sensitive. Pancreatic insulin secretion has not been evaluated. 28 Middle panel: HSL-null mice from Mitchell's group bred on a C57BL/6 genetic background show normoglycemia and normo or hypoinsulinemia. Liver and adipose tissue (to be confirmed) are insulinsensitive whereas skeletal muscles display age-and sex-related insulin resistance. Pancreatic insulin secretion is altered. 17, 29, 30 Lower panel: HSL-null mice from Holm's group bred on a mixed genetic background show hyperglycemia and hyperinsulinemia. Liver, adipose tissue and skeletal muscles are sites of insulin resistance. Pancreatic insulin secretion is normal.
11 FFA, free fatty acid; IS, insulin sensitivity; LD, lipid droplet; NI, noninvestigated; PPAR, peroxysome proliferation-activated receptor.
Animal 39 Global insulin sensitivity tested in vivo was improved in ATGL-null mice on both a chow diet and HFD. 36, 38 Glucose tolerance was improved depending on the genetic background. 36, 40 The reduction in FA availability is likely to favor glucose utilization. Kienesberger et al.
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support skeletal muscles as the major mediator of enhanced insulin sensitivity in these mice. However, this observation is difficult to reconcile with increased accumulation of TAG and DAG in this tissue. Fuel and non-fuel-stimulated insulin secretary function was altered by ATGL disruption. 40 Changes in signalling lipids derived from islet lipolysis rather than islet TAG accumulation is thought to be implicated in the impairment of stimulated insulin secretion. In conclusion, ATGL-null mice display a complex multi-organ phenotype emphasizing the importance of this lipase in non-adipose organs. However, it is clear that ATGL has a major role in adipose tissue lipolysis and is the rate-limiting enzyme for the first step of TAG breakdown. Table 2 summarizes the major phenotypic features of both HSL and ATGL-null mice. Ahmadian et al. 42 created a mouse model of adiposespecific ATGL overexpression under the control of the fabp4 promoter. ATGL mRNA expression is increased more than fourfold and threefold in white and brown adipose tissue, respectively. At the protein level, ATGL expression is doubled in both tissues. The rise in ATGL expression in white adipose tissue is accompanied by a marked increase in TAG hydrolase activity in vitro. Notably, ATGL over expression in white adipose tissue leads to an increase in the expression of its co-activator ABHD5. Basal lipolysis is increased and stimulated lipolysis is raised by B50%. The latter result fits with the postulated role of ATGL in stimulated lipolysis supported by in vitro observations. 6, 43 Lipid metabolism investigated in vitro and in vivo is slightly modified by ATGL over expression, raising the possibility of changes in re-esterification fluxes in transgenic mice. When fed a normal chow diet, transgenic mice grow up normally and do not manifest any difference in weight whereas when the mice are placed on a HFD, ATGL overexpression leads to leaner animals with smaller fat pads. The reduced adipocyte size observed in the transgenic animals concurs with in vitro data showing that LD size is decreased following ATGL overexpression. 44 The decreased fat deposition was not due to a diminution in food intake or a defect in adipogenesis but rather to a rise in energy expenditure presumably driven by increased FA oxidation in white adipose tissue and, glucose uptake and utilization in skeletal muscles. ATGLoverexpressing mice showed improved insulin sensitivity assessed by hyperinsulinemic euglycemic clamp. It is puzzling that both ATGL deletion and overexpression leads to improvement of insulin sensitivity. It is also intriguing that ATGL and HSL overexpression are not associated with phenotypes that mirror those of ATGL-and HSL-null mice (Table 2 ).
Other lipases Monoglyceride lipase. MGL catalyzes the final step of TAG breakdown by hydrolyzing MAG to glycerol and FA. This 33 kDa lipase belongs to the serine hydrolase superfamily. 45 In vitro studies provided the evidence that MGL specifically hydrolyzes MAG (1(3) and 2-ester bonds equivalently) and has no activity against TAG or DAG. MGL is therefore essential for complete TAG hydrolysis. At a cellular level, MGL is located in the cytoplasm, plasma membrane and on LDs. MGL is widely expressed including white adipose tissue, lung, liver, kidneys, testes, brain and heart. 46 It is unlikely that MGL is limiting in lipolysis as it is very abundant in white adipose tissue and is not extensively regulated by nutritional status in this tissue; 13 however, the study of MGL-null mice invalidates this hypothesis since ex vivo stimulated lipolysis is decreased in these animals. 47 MGL disruption in vivo causes a decrease in MG hydrolase activity partially compensated by HSL, nevertheless MG accumulation observed in adipose tissue and liver did not affect body weight or fat deposition. MGL-deleted mice show a partial protection toward diet-induced insulin resistance and glucose intolerance suggesting that the limitation of FA release from adipose tissue might be beneficial. 47 The metabolic phenotype of MGL-null mice can, however, be Animal models for the study of lipolysis A Girousse and D Langin influenced by central effects since MGL disruption dramatically affects brain endocanabinoid system through MGL function. 47, 48 TAG hydrolases (TGH). TGHs including TGH-1 (first described as TGH/Ces3) and TGH-2 (Ces1f) are members of the carboxyl esterase family that manifests several similarities in protein structure and function. 49, 50 Both TGH-1 and TGH-2 are mainly expressed in liver but also in adipose tissue, small intestine and kidney. TGH-1 is expressed in cardiac muscle. These enzymes preferentially hydrolyze TAG (short chain more than long chain FA TAG) and do not act on DAG, phospholipids or cholesteryl esters. In vitro experiments implicating TGH-1 and TGH-2 in adipose tissue TAG mobilization remain conflicting. 50-55 TGH-1-null mice resulting from exon 5 disruption do not express the TGH protein. 56 Total in vitro hydrolase activity of adipose tissue is 70% decreased when TGH-1 is lacking ( Figure 2 ). As a MAG analog was used as the substrate rather than a real TAG; in vitro hydrolase activity against TAG should be re-evaluated in order to ascertain the real impact of adipose TGH-1 deletion on TAG breakdown. Moreover, in vitro deletion of ATGL and HSL leads to negligible residual TAG hydrolase activity suggesting a minor role for TGH in TG breakdown. 6 ,55 Impaired fat mobilization was, however, suggested by measurement of plasma FA and glycerol levels in fed and fasted states. 56 TGH-1-null mice manifest enlarged white adipose tissue depots (70%) associated with increased adipocyte size. Although fat mass is modified, TGH-1 deletion affects predominantly the liver with a significant reduction in weight, TAG accumulation, lipolysis and verylow-density lipoprotein secretion and probably increased FA oxidation. The regulation of energy balance in TGH-1-null mice remains puzzling as fat mass and food intake are increased but body weight is unchanged. As TGH is expressed in the intestine, enzyme disruption could affect lipid absorption and/or food intake through modulation of gastrointestinal peptide production. Global improvement of glucose tolerance and insulin sensitivity was observed in TGH-1-null mice. Tissue-specific TGH-1-null mice could help in discerning the relative importance of adipose tissue versus liver in the observed improvement of the metabolic features. Furthermore, adipose-specific double TGH-1/TGH-2-null mice associated with in vitro deletions could represent useful models to completely abrogate TGH activity in adipocytes and settle the importance of these lipases in lipolysis. [59] [60] [61] ABHD5 also has transacylase enzyme activity. 34 Yang et al. 62 have recently reported a splicing variant isoform of murine ABHD5 that lacks the ability to activate ATGL but maintains its transacylase function. The control of ABHD5 pre-mRNA splicing could hypothetically be involved in the modulation of lipolysis. Zechner's group produced animals in which the ABHD5 gene was deleted. No ABHD5 protein was detected in adipose tissue. 63 TAG hydrolase activity and consequently lipolysis measured in mouse embryonic fibroblasts were markedly reduced in the absence of ABHD5 leading to increased TAG accumulation. ABHD5-null newborns manifest two major features: (1) ectopic TAG accumulation in several tissues including non-adipose tissues and (2) impaired development of the skin permeability barrier that led to premature death just after birth, limiting the metabolic characterization in vivo. Part of the phenotype is probably explained by the inability of ABHD5 to activate ATGL as is the case in the human disease. 58 However, the skin defect is not attributable to its interaction with ATGL. The putative enzyme involved in mediating this skin phenotype is still to be characterized. This phenotype clearly suggests a major role of ABHD5 in TAG metabolism. An adipose tissue-and time-specific deletion of ABHD5 would be valuable to further dissect the role of this protein in vivo.
G0/G1 switch gene 2 G0/G1 switch gene 2 (G0S2) encodes a protein first described in human mononuclear cells as possibly involved in cell cycle regulation. G0S2 is expressed at high levels in white and brown adipose tissues and to a lesser extent in liver, skeletal muscle and heart. In adipocytes, G0S2 colocalizes with ATGL on LDs 62 and has an important role in lipolysis inhibiting ATGL activity. G0S2 binds directly to ATGL and dose-dependently inhibits its TAG hydrolase activity regardless of the presence of ABHD5. G0S2 could (1) affect substrate accessibility to ATGL, (2) alter ATGL conformation or (3) divert ATGL primary TAG hydrolase function to an acyl transferase activity. The role of G0S2 at the LD and competition with ABHD5 require further study. 64 In conclusion, Thanks to a null mutation in the fabp4 gene, Hotamisligil and Spiegelman created animals that completely lacked FABP4 protein in adipose tissue. 71 FABP4 deletion is partially compensated for by the upregulation of FABP5. The effect of FABP4 deletion on TAG hydrolase activity is not known but in vitro and in vivo lipolysis are reduced following FABP4 disruption. 65, [72] [73] [74] The body weight of FABP4 knockout mice is normal on a standard chow diet. When fed a HFD, weight gain is similar to that of wild-type mice, but white adipose tissue mass is increased. 65, 71 The increase in white adipose tissue mass despite similar food intake and normal or diminished energy expenditure could result from gene expression re-programming in adipose tissue promoting de novo lipogenesis. Surprisingly, the diet-induced obesity developed by FABP4-null mice was uncoupled from insulin resistance and adipose tissue inflammation. 71 An increase in adiponectin and reduced expression of TNFa were proposed to participate in the mechanism of protection of insulin sensitivity. 65, 71 This model suggests that besides direct modification of enzyme activity and alteration of LD protein content, other regulatory nodes of lipolysis exist such as FA handling.
PAT proteins and other LD-associated proteins PAT family. LDs are surrounded by a phospholipid monolayer coated with several proteins collectively grouped in the PAT family. This group includes perilipins, ADRP (also called adipophilin), Tip-47 (tail-interacting protein of 47 kDa), hence the acronym PAT, but also S3-12 and OXPAT (a PAT family protein expressed in oxidative tissues also termed MLDP or LSDP5). A recent unified nomenclature has been proposed for these proteins; they should be respectively named PLIN1, PLIN2, PLIN3, PLIN4 and PLIN5 (ref. 75) ( Table 1) . Expression of PLIN1 (perilipin, products of the Plin gene) and PLIN 4 (S3-12) is chiefly limited to white adipose tissue, PLIN1 being also expressed in brown adipose tissue. PLIN1 is expressed at lower levels in steroidogenic tissues and PLIN4 in heart and skeletal muscles. PLIN1 has three isoforms; PLIN1a and PLIN1b are respectively the major and the minor forms on adipocyte LD while PLIN1c is only expressed in non-adipose tissues. PLIN5 (OXPAT) is mainly expressed in tissues with high oxidative capacities such as brown adipose tissue and skeletal muscles whereas PLIN2 (ADRP) and PLIN3 (Tip-47) are more ubiquitously expressed in cells containing LDs. Here, we will focus on adipose tissueexpressed PLIN. PLIN1 has been extensively studied in cellular models. 3 Two independent animal models of plin1 deletion targeting exon 2 or exons 5 and 6 were produced and lead to the complete absence of PLIN1 in adipose tissue. 76, 77 PLIN1 deletion is associated with increased DAG hydrolase activity in white adipose tissue whereas the level of HSL protein is constant. 76 PLIN1-null mice show increased in vitro basal lipolysis ( Figure 4 ) and blunted stimulated lipolysis. The rise in basal lipolysis was initially attributed to increased HSL activity, however, there are still discrepancies about HSL quantification in the tissue and involvement of other TAG hydrolases had not been evaluated at the time of the experiment. In the light of new information related to protein-protein interactions between PLIN1 and ABHD5, PLIN1 depletion could also have an impact on ABHD5-mediated ATGL activity in basal conditions. Surprisingly, in vivo basal lipolysis on the other hand is not modified indicating other regulatory mechanisms implicated at the whole organism level. On a chow diet, PLIN1-null mouse body weight is not modified. 76, 77 The reduced fat mass (associated with decreased adipocyte size and TAG content) is compensated for by increased lean mass. PLIN1-null mice are resistant to diet and genetic-induced obesities presumably due to increased energy expenditure, because food intake is increased or unchanged. White adipose tissue manifests a pro-oxidative profile with upregulation of several genes involved in b-oxidation and increased palmitate oxidation. 78, 79 The ATGL overexpression model also shows increased basal lipolysis and decreased stimulated lipolysis associated with a rise of oxidative capacity. It could be speculated that the adipose tissue phenotype observed in PLIN1-null mice chiefly results from increased ATGL/ABHD5 activity. As PLIN1-null mice are more oxidative, insulin sensitivity might be improved in this model. That is the case for young animals (until 14 weeks); however, glucose intolerance and insulin resistance is observed with ageing in PLIN1-deleted mice. It is unknown whether the deterioration in insulin sensitivity is associated with impaired oxidative capacity.
Animal models for the study of lipolysis A Girousse and D Langin
Adipose tissue-specific human or murine plin1 overexpression in mice 80 led to a twofold and fivefold increase in PLIN1 protein expression in white and brown adipose tissue, respectively. The effect of PLIN1 overexpression on TAG hydrolase activity was not determined. Basal lipolysis assessed in isolated adipocytes from mice fed normal chow diet was not altered in transgenic mice whereas it was decreased on a HFD. PLIN1 overexpression led to a reduction in stimulated lipolysis in transgenic mice regardless of the diet (except for the murine transgene in HFD condition). This observation fits with the functional role of PLIN1 as a LD barrier. The consequences on body weight were gender and transgene dependent. 80 When fed a normal chow diet, transgenic mice were a similar weight to wild-type control mice whereas, similarly to PLIN1-null mice, they displayed resistance to HFD-induced obesity. Again, similarly to PLIN1-deleted mice, an increase in energy expenditure and up regulation of b-oxidation gene expression was observed in white and brown adipose tissues of mice overexpressing PLIN1 and was thought to drive the lean phenotype. 80, 81 White adipose tissue was also characterized by reduced expression of Cidec/Fsp27 (see below), which was thought to trigger decreased LD size. 81 Glucose homeostasis was not modified in transgenic mice fed chow diet but PLIN1 overexpression protected mice against HFD-induced glucose intolerance and insulin intolerance. Finally, it is interesting to note that a reduction and increase in PLIN1 expression result in blunted stimulated lipolysis implying that precise regulation of this protein at the surface of the LD is essential for the lipolytic process.
PLIN2 invalidation model. Although PLIN2 is expressed in white adipose tissue, its deletion in mice has a minor impact on this tissue as lipolysis was not affected in PLIN2-null mice 82 suggesting that (i) PLIN2 is not involved in the regulation of lipolysis and that (ii) the absence of PLIN2 is not compensated for by other PAT proteins. PLIN2 deletion has a more significant impact on the liver as PLIN2-null mice fed a HFD were protected from HFD-induced hepatic steatosis.
PLIN3. PLIN3 deletion or overexpression has not been investigated in transgenic models. However, such models could be of interest as when PLIN3 expression was reduced in liver cells lipolysis was increased because of greater ATGL localization to the LD. 83 Furthermore, Beller et al. 84 highlighted the importance of the coat protein complex I in the regulation of PLIN3 localization at the LD surface. As a result of the coat protein complex I trafficking, ATGL LD localization is also prevented and lipolysis is reduced. Together these results reinforce the potential role of LD-associated proteins in the control of lipolysis and emphasize the need for novel animal models to investigate integrated mechanisms.
CIDE family. Over the past few years, new LD-associated proteins have been described such as proteins of the CIDE family (cell death-inducing DNA fragmentation factor-a-like effector). The CIDE family includes three members (Cidea, Cideb and Cidec/Fsp27) presenting tissue-specific expression. 85 Although Cidea and Cideb are not expressed in mouse white adipose tissue, their deletion in vivo led to a leaner phenotype and resistance to diet-induced obesity associated with insulin sensitivity. 86, 87 In both models, the rise in global energy expenditure is driven by a unique organ, respectively brown adipose tissue and liver. Cidea depletion may stabilize the AMPK (5 0 adenosine monophosphate-activated protein kinase) complex thus enhancing its activity and promoting FA oxidation. 88 The lean phenotype of Cidebnull mice may result from reduced hepatic very-low-density lipoprotein secretion and de novo FA synthesis associated with enhancement of hepatic oxidative capacities.
89
Fsp27 was first identified as a protein up regulated during adipogenesis and highly expressed in murine white and brown adipose tissues. 86, 90 Puri et al. 91 demonstrated in vitro that Fsp27 subcellular localization in adipocyte was Figure 4 Phenotypic consequences of alterations in LD-associated protein content. Alteration of both PLIN1 and Cidec/Fsp27 content affect LD morphology. In both cases, basal lipolysis is increased leading to the rise of intracellular concentration of FA. PLIN1-null and Cidec-null mice adipocytes present mitochondrial biogenesis that is linked only in Cidec-null mice to local increased FA mitochondrial oxidation. In PLIN1-null mice, FA are exported out the adipocyte and handled and oxidized in liver and skeletal muscles. Whatever the site of FA oxidation, insulin sensitivity is improved. FA, fatty acid; FSP27, fat-specific protein 27 (Cidec); IS, insulin sensitivity; LD, lipid droplet; PLIN1, perilipin; PPAR, peroxisome proliferator-activated receptor.
Animal models for the study of lipolysis A Girousse and D Langin restricted to the LD-like PLIN1 but constituting a more discontinuous ring. Two in vivo models of Fsp27 deletion (targeting either the first two exons or the translation start codon in exon 2) led to the complete absence of Fsp27 protein in white and brown adipose tissues. 92, 93 Fsp27 deletion increased basal lipolysis whereas stimulated lipolysis was not affected 92 or decreased. 93 Both groups depicted changes in white adipose tissue morphology with increased vascularization, brown color and interestingly multilocularization of LD (Figure 4) . Although no major effects of Fsp27 deletion were noted at the whole body level when mice were fed a standard chow diet (besides an age-related reduction in white adipose tissue), HFD-fed Fsp27-null mice failed to become obese because of raised energy expenditure associated with increased mitochondrial biogenesis and oxidative capacities. The white adipose tissue phenotype was thought to favor improved insulin sensitivity in Fsp27-null mice. Together these results emphasize a major role of Fsp27 in LD metabolism and at a larger scale in energy homeostasis.
Concluding remarks
During the last decade, cellular approaches and molecular resources have facilitated considerable progress in our understanding of the regulation of lipolysis. They helped in describing lipase recruitment to the LD in response to protein kinase stimulation and the dynamic trafficking of lipases with regulatory proteins. The study of transgenic mouse models offered new angles and an integrated perspective. They revealed changes in adipose tissue morphology and metabolism. In vivo lipase disruption emphasized their importance in adipose and, especially for ATGL, non-adipose tissues. Disruption of the LD barrier had dramatic consequences on adipose function, as predicted by cellular approaches. Most of the models presented in this review revealed moderate to strong resistance to dietinduced obesity underlying the importance of basal lipolysis in the modification of body weight and fat mass ( Figure 5 ). However, differences between mice and human concerning the regulation of lipolysis should be borne in mind. 2 In vivo approaches also documented the consequences of modulations in lipolysis on energy metabolism and insulin sensitivity. One interesting feature observed is the more or less pronounced 'brown adipose tissue-like' phenotype acquired by white adipose tissue consecutive to lipase and associated protein deletion. White adipose tissue manifested increased oxidative capacities that were accompanied by an improvement in insulin sensitivity. Making white adipocytes 'browner' may be viewed as the Holy Grail. 94 However, the links between FA fluxes in adipocyte and mitochondrial metabolism reprogramming still needs to be studied in depth. Another attractive axis resides in studying besides LD stabilization, the LD formation itself (reviewed in Farese and Walther
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). Transgenic mouse models suffer from a number of limitations that confound phenotypic interpretation. As lipases are not only expressed in adipose tissue but also often in several non-adipose organs such as liver, skeletal muscles or steroidogenic tissues, complete deletion of these proteins in animals drives complex metabolic consequences Animal models for the study of lipolysis A Girousse and D Langin not only resulting from the alteration of adipose tissue lipolysis. Moreover, lipases such as HSL are endowed with multiple tissue-dependent enzyme activities that confuse the global interpretation of the phenotype. Adipose tissuespecific deletion could be of a great interest in these cases and also in case of premature death or growth defect such as with ATGL and ABHD5-null mice. Given that HSL and ATGL are both significantly expressed in skeletal muscle and in the pancreas, specific targeting in adipose tissue could also help in deciphering tissue-specific effects on insulin sensitivity. Adipose tissue targeting classically employs a 5.4-kb fabp4 promoter segment 96 and the Cre-loxP system. However, fabp4 promoter adipose-specific expression has been questioned as ectopic recombination may occur in the central and peripheral nervous system, 97,98 macrophage 99,100 and endothelial cells. 101 The adipose driven expression conveyed by the adiponectin promoter appears to be more efficient. 102 This molecular resource offers new perspectives for adiposespecific functional studies. The use of multiple deletion models and/or heterozygous models represent attractive approaches to overcoming the limitations of total knock-outs such as non-physiological complete depletion and resulting compensatory phenotypes and, may mimic more closely the human obese phenotype. 103, 104 Pharmacological inhibition of lipolysis would also be a valuable strategy. In vivo experiments showed that HFD-fed animals treated with acipimox, the nicotinic receptor agonist, have reduced plasma FA levels along with improved insulin sensitivity. 105 With a view to limiting deleterious FA release characterizing the metabolic syndrome, several pharmaceutical groups have started to develop small-molecule modulators of lipolysis including HSL inhibitors. 106, 107 MGL and TGH inhibitors are also available for in vitro purposes. [108] [109] [110] As an alternative to transgenic models one could consider in vivo pharmacological chronic treatments with such molecules. However, pharmacological approaches fail to address caveats linked to tissue specificity.
In conclusion, despite the limitations listed above, animal models still represent powerful resources to define gene functions. They retain a prime and irreplaceable place linking in vitro approaches to clinical studies. Understanding of adipose tissue lipolysis remains of major interest to delineate new preventive and therapeutic strategies to address the medical issues related to obesity and its associated complications.
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